1. Home
  2. ENTX vs DHX Comparison

ENTX vs DHX Comparison

Compare ENTX & DHX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENTX
  • DHX
  • Stock Information
  • Founded
  • ENTX 2010
  • DHX 1991
  • Country
  • ENTX Israel
  • DHX United States
  • Employees
  • ENTX N/A
  • DHX N/A
  • Industry
  • ENTX Biotechnology: Biological Products (No Diagnostic Substances)
  • DHX Business Services
  • Sector
  • ENTX Health Care
  • DHX Consumer Discretionary
  • Exchange
  • ENTX Nasdaq
  • DHX Nasdaq
  • Market Cap
  • ENTX 104.0M
  • DHX 89.7M
  • IPO Year
  • ENTX 2018
  • DHX 2007
  • Fundamental
  • Price
  • ENTX $1.94
  • DHX $2.30
  • Analyst Decision
  • ENTX Strong Buy
  • DHX Strong Buy
  • Analyst Count
  • ENTX 1
  • DHX 2
  • Target Price
  • ENTX $10.00
  • DHX $5.25
  • AVG Volume (30 Days)
  • ENTX 35.9K
  • DHX 142.0K
  • Earning Date
  • ENTX 05-09-2025
  • DHX 05-07-2025
  • Dividend Yield
  • ENTX N/A
  • DHX N/A
  • EPS Growth
  • ENTX N/A
  • DHX N/A
  • EPS
  • ENTX N/A
  • DHX N/A
  • Revenue
  • ENTX $223,000.00
  • DHX $138,202,000.00
  • Revenue This Year
  • ENTX N/A
  • DHX N/A
  • Revenue Next Year
  • ENTX N/A
  • DHX $0.88
  • P/E Ratio
  • ENTX N/A
  • DHX N/A
  • Revenue Growth
  • ENTX N/A
  • DHX N/A
  • 52 Week Low
  • ENTX $1.41
  • DHX $1.21
  • 52 Week High
  • ENTX $2.79
  • DHX $3.32
  • Technical
  • Relative Strength Index (RSI)
  • ENTX 47.15
  • DHX 69.40
  • Support Level
  • ENTX $1.69
  • DHX $1.98
  • Resistance Level
  • ENTX $2.08
  • DHX $2.14
  • Average True Range (ATR)
  • ENTX 0.13
  • DHX 0.17
  • MACD
  • ENTX -0.02
  • DHX 0.04
  • Stochastic Oscillator
  • ENTX 58.14
  • DHX 90.91

About ENTX Entera Bio Ltd.

Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to significantly shift a treatment paradigm. Its product candidates are; EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are first-in-class mini tablet formulations of synthetic human PTH (1-34) (teriparatide), designed to have differing pharmacokinetic, or PK, profiles.

About DHX DHI Group Inc.

DHI Group Inc is a provider of artificial intelligence-powered software products, online tools and services to deliver career marketplaces to candidates and employers globally. DHI's brands includes Dice and Clearance Jobs enable recruiters and hiring managers to efficiently search, match and connect with skilled technologists in specialized fields, particularly technology and those with active government security clearances. The company derive the majority of revenue came from the sale of recruitment packages, which allow customers to promote jobs on websites and source candidates through their resume databases. Recruitment packages are typically provided through contractual arrangements with annual, quarterly or monthly payment terms.

Share on Social Networks: